These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32697807)

  • 1. Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance.
    Hagberg L; Price RW; Zetterberg H; Fuchs D; Gisslén M
    PLoS One; 2020; 15(7):e0236162. PubMed ID: 32697807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid pleocytosis as a predictive factor for CSF and plasma HIV RNA discordance and escape.
    de Almeida SM; Rotta I; de Pereira AP; Tang B; Umlauf A; Ribeiro CEL; Letendre S; Ellis RJ;
    J Neurovirol; 2020 Apr; 26(2):241-251. PubMed ID: 32002817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
    Spudich SS; Nilsson AC; Lollo ND; Liegler TJ; Petropoulos CJ; Deeks SG; Paxinos EE; Price RW
    BMC Infect Dis; 2005 Nov; 5():98. PubMed ID: 16266436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid virology in people with HIV.
    Henderson M; Pepper N; Bawa M; Muir D; Everitt A; Mackie NE; Winston A
    HIV Med; 2023 Jul; 24(7):838-844. PubMed ID: 36895097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms.
    Kugathasan R; Collier DA; Haddow LJ; El Bouzidi K; Edwards SG; Cartledge JD; Miller RF; Gupta RK
    Clin Infect Dis; 2017 Apr; 64(8):1059-1065. PubMed ID: 28329096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia.
    Nightingale S; Geretti AM; Beloukas A; Fisher M; Winston A; Else L; Nelson M; Taylor S; Ustianowski A; Ainsworth J; Gilson R; Haddow L; Ong E; Watson V; Leen C; Minton J; Post F; Pirmohamed M; Solomon T; Khoo S
    J Neurovirol; 2016 Dec; 22(6):852-860. PubMed ID: 27194435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid pleocytosis is associated with HIV-1 neuroinvasion during acute infection.
    Chan P; Moreland S; Sacdalan C; Kroon E; Colby D; Sriplienchan S; Pinyakorn S; Phanuphak N; Jagodzinski L; Valcour V; Vasan S; Paul R; Trautmann L; Spudich S;
    AIDS; 2024 Mar; 38(3):373-378. PubMed ID: 37916464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
    Joseph SB; Kincer LP; Bowman NM; Evans C; Vinikoor MJ; Lippincott CK; Gisslén M; Spudich S; Menezes P; Robertson K; Archin N; Kashuba A; Eron JJ; Price RW; Swanstrom R
    Clin Infect Dis; 2019 Sep; 69(8):1345-1352. PubMed ID: 30561541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
    Gisslen M; Keating SM; Spudich S; Arechiga V; Stephenson S; Zetterberg H; Di Germanio C; Blennow K; Fuchs D; Hagberg L; Norris PJ; Peterson J; Shacklett BL; Yiannoutsos CT; Price RW
    PLoS One; 2021; 16(5):e0250987. PubMed ID: 33983973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India.
    Dravid AN; Natrajan K; Kulkarni MM; Saraf CK; Mahajan US; Kore SD; Rathod NM; Mahajan US; Wadia RS
    Medicine (Baltimore); 2018 Feb; 97(8):e9969. PubMed ID: 29465595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF.
    Nightingale S; Michael BD; Fisher M; Winston A; Nelson M; Taylor S; Ustianowski A; Ainsworth J; Gilson R; Haddow L; Ong E; Leen C; Minton J; Post F; Beloukas A; Borrow R; Pirmohamed M; Geretti AM; Khoo S; Solomon T
    Cytokine; 2016 Jul; 83():139-146. PubMed ID: 27131579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection.
    Sinclair E; Ronquillo R; Lollo N; Deeks SG; Hunt P; Yiannoutsos CT; Spudich S; Price RW
    J Acquir Immune Defic Syndr; 2008 Apr; 47(5):544-52. PubMed ID: 18362693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
    Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
    J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana.
    Kelentse N; Moyo S; Mogwele M; Lechiile K; Moraka NO; Maruapula D; Seatla KK; Esele L; Molebatsi K; Leeme TB; Lawrence DS; Musonda R; Kasvosve I; Harrison TS; Jarvis JN; Gaseitsiwe S
    Medicine (Baltimore); 2020 Oct; 99(41):e22606. PubMed ID: 33031315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious causes and outcomes in patients presenting with cerebral spinal fluid pleocytosis.
    Brown BL; Fidell A; Ingolia G; Murad E; Beckham JD
    J Neurovirol; 2019 Aug; 25(4):448-456. PubMed ID: 30850974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study.
    Ulfhammer G; Edén A; Antinori A; Brew BJ; Calcagno A; Cinque P; De Zan V; Hagberg L; Lin A; Nilsson S; Oprea C; Pinnetti C; Spudich S; Trunfio M; Winston A; Price RW; Gisslén M
    Clin Infect Dis; 2022 Aug; 75(3):493-502. PubMed ID: 34747481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults.
    Mukerji SS; Misra V; Lorenz D; Cervantes-Arslanian AM; Lyons J; Chalkias S; Wurcel A; Burke D; Venna N; Morgello S; Koralnik IJ; Gabuzda D
    J Acquir Immune Defic Syndr; 2017 Jun; 75(2):246-255. PubMed ID: 28328546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.
    Marra CM; Maxwell CL; Collier AC; Robertson KR; Imrie A
    BMC Infect Dis; 2007 May; 7():37. PubMed ID: 17475004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations.
    Smith DM; Zárate S; Shao H; Pillai SK; Letendre SL; Wong JK; Richman DD; Frost SD; Ellis RJ;
    Virology; 2009 Mar; 385(1):204-8. PubMed ID: 19100592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment.
    Edén A; Fuchs D; Hagberg L; Nilsson S; Spudich S; Svennerholm B; Price RW; Gisslén M
    J Infect Dis; 2010 Dec; 202(12):1819-25. PubMed ID: 21050119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.